Diagnosis of preeclampsia in women with diabetic kidney disease

References

• Kornacki J, Skrzypczak J. Preeclampsia- two manifestations of the same disease. Ginekol Pol. 2008;79:432–437.
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC. The hypertensive disorders of pregnancy: iSSHPclassification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–e260.
   PubMed Web of Science ®Google Scholar
• Wiles K, Chappell LC, Lightstone L, et al. Updates in diagnosis and management of preeclampsia in women with CKD. Clin J Am Soc Nephrol. 2020;15(9):1371–1380.
   PubMed Web of Science ®Google Scholar
• Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspectives. Kidney Int Suppl. 2018;8(1):2–7.
   Web of Science ®Google Scholar
• Gutaj P, Zawiejska A, Mantaj U, et al. Determinants of preeclampsia in women with type 1 diabetes. Acta Diabetol. 2017;54(12):1115–1121.
   PubMed Web of Science ®Google Scholar
• Klemetti MM, Laivuori H, Tikkannen M, et al. Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011. Diabetologia. 2015;58(4):678–686.
   PubMed Web of Science ®Google Scholar
• Young EC, Pires MLE, Marques LPJ, et al. Effects of pregnancy on the onset and progression of diabetic nephropathy and of diabetic nephropathy on pregnancy outcomes. Diabetes Metab Syndr. 2011;5(3):137–142.
   PubMedGoogle Scholar
• Wender-Ożegowska E, Gutaj P, Mantaj U, et al. Pregnancy outcomes with long - duration type 1 diabetes – 25 years of experience. J Clin. Med. 2020 Oct 8 9(10);3223. 10.5603.
   Google Scholar
• Atallah A, Lecarpentier E, Goffinet F, et al. Aspirin for Prevention of Preeclampsia. Drugs. 2017;77(17):1819–1831.
   PubMed Web of Science ®Google Scholar
• Hare JW, and White P. Gestational diabetes and the White classification. Diabetes Care.1980;3:394.
   Google Scholar
• Wender-Ożegowska E, Bomba-Opoń D, and Brązert J, et al. Standardy polskiego towarzystwa ginekologów i położników postępowania u kobiet z cukrzycą Ginekologia i Perinatologia Praktyczna. 2017;2(5): 215–219.
   Google Scholar
• Gordijn SJ, Beune IM, Thilaganathan B, et al. Consensus definition on fetal growth restriction: a delphi procedure. UOG. 2016;48(3):333–339.
   Google Scholar
• Prejbisz A, Dobrowolski P, Kosiński P, et al. Management of hypertension in pregnancy –
   Google Scholar
• Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines.
   Google Scholar
• Roberts JM, Hubel CA The two stage model of preeclampsia: variations on the theme.
   Google Scholar
• Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642–649.
   PubMed Web of Science ®Google Scholar
• Rahman S, Rahman T, Ismail AA, et al. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9(6):767–780.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, and Rosei EA. Small artery remodelling in diabetes mellitus. Nutr Metab Cardiovasc Dis. 2009;19:587-592.
   Google Scholar
• Tousoulis D, Kampoli AM, Stefanadis C Diabetes mellitus and vascular endothelial
   Google Scholar
• Kornacki J, Wirstlein P, Wender–Ożegowska E. Levels of syndecan-1 and hyaluronan in early - and late-onset preeclampsia. Pregnancy Hypertens. 2019;18:108–111.
   PubMed Web of Science ®Google Scholar
• Vestgaard M, Sommer MC, Ringholm L, et al. Prediction of preeclampsia in type 1 diabetes in early pregnancy by clinical predictors: a systematic review. J Matern Fetal Neonatal Med. 2018;31(14):1933–1939.
   PubMed Web of Science ®Google Scholar
• Ekbom P, Damm P, Rasmussen-Feldt B, et al. Pregnancy Outcome in Type 1 Diabetic
   Google Scholar
• Howarth G, Gazis A, James D, et al. Association of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med. 2007;24(11):1229–1234.
   PubMed Web of Science ®Google Scholar
• Hanson U, Persson B. Epidemiology of pregnancy induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. SOBS. 1998;77(6):620–624.
   Google Scholar
• Lopes Van Balen VA, Van Gansewinkel TAG, De Haas S. Maternal kidney function during pregnancy: systematic review and meta-analysis. UOG. 2019;54:297–307.
   Google Scholar
• Sorohan BM, Andronesi A, Ismail G, et al. Clinical Predictors of Preeclampsia in Pregnant
   Google Scholar
• Feig DS, Corcoy R, Donovan LE, et al. Pumps or Multiple Daily Injections in Pregnancy
   Google Scholar
• Lapolla A, Dalfra MG, Masin M, et al. Analysis of outcome of pregnancy in type 1 diabetes treated with insulin pump or conventional insulin therapy. Acta Diabetol. 2003;40(3):143–149.
   PubMed Web of Science ®Google Scholar
• Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease; the Italian study group on kidney and pregnancy. J Nephrol. 2016;29:277–303.
   PubMed Web of Science ®Google Scholar
• Rolfo A, Attini R, Nuzzo AM, et al. Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int. 2013;83(1):177–181.
   PubMed Web of Science ®Google Scholar
• Masuyama H, Nobumoto E, and Okimoto N, et al. Superimposed preeclampsia in women with chronic kidney disease. Gynecol Obstet Invest. 2012;74(4):274–281.
   PubMed Web of Science ®Google Scholar
• Kornacki J, Wirstlein P, Wender–Ożegowska E. Markers of Endothelial Injury and
   Google Scholar
• Wiles K, Bramham K, Seed PT, et al. Diagnostic indicators of superimposed preeclampsia in women with CKD. Kidney Int Rep. 2019;4(6):842–853.
   PubMed Web of Science ®Google Scholar
• Caritis S, Sibai B, and Hauth J. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338 (11):701-705.
   Google Scholar
• Goffinet, F , Breart, G, and Uzan , S ECPPA: randomized trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynecol. 1996;103(7):719–720.
   PubMedGoogle Scholar
• Poon L, Wright D, Rolnik DL, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217 950(5):585 e1–585 e5.
   Web of Science ®Google Scholar
• Banala C, Moreno S, Cruz Y, et al. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2020;223(419):e1–16.
   PubMedGoogle Scholar